Frequency Therapeutics Stock Current Valuation
| KRRO Stock | 34.12 0.06 0.18% |
Valuation analysis of Frequency Therapeutics helps investors to measure Frequency Therapeutics' intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns. As of the 1st of February 2025, Enterprise Value Over EBITDA is likely to grow to 0.68. Also, Enterprise Value Multiple is likely to grow to 0.68. Fundamental drivers impacting Frequency Therapeutics' valuation include:
Undervalued
Today
Please note that Frequency Therapeutics' price fluctuation is very steady at this time. Calculation of the real value of Frequency Therapeutics is based on 3 months time horizon. Increasing Frequency Therapeutics' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Frequency Therapeutics is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Frequency Stock. However, Frequency Therapeutics' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 34.12 | Real 59.69 | Target 137.76 | Hype 31.67 | Naive 36.95 |
The intrinsic value of Frequency Therapeutics' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Frequency Therapeutics' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Frequency Therapeutics helps investors to forecast how Frequency stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Frequency Therapeutics more accurately as focusing exclusively on Frequency Therapeutics' fundamentals will not take into account other important factors: Frequency Therapeutics Company Current Valuation Analysis
Frequency Therapeutics' Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Frequency Therapeutics Current Valuation | 225 M |
Most of Frequency Therapeutics' fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Frequency Therapeutics is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Frequency Current Valuation Driver Correlations
Understanding the fundamental principles of building solid financial models for Frequency Therapeutics is extremely important. It helps to project a fair market value of Frequency Stock properly, considering its historical fundamentals such as Current Valuation. Since Frequency Therapeutics' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Frequency Therapeutics' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Frequency Therapeutics' interrelated accounts and indicators.
Click cells to compare fundamentals
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Frequency Therapeutics has a Current Valuation of 225 M. This is 98.43% lower than that of the Biotechnology sector and 95.16% lower than that of the Health Care industry. The current valuation for all United States stocks is 98.65% higher than that of the company.
Frequency Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Frequency Therapeutics' direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Frequency Therapeutics could also be used in its relative valuation, which is a method of valuing Frequency Therapeutics by comparing valuation metrics of similar companies.Frequency Therapeutics is currently under evaluation in current valuation category among its peers.
Frequency Therapeutics ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Frequency Therapeutics' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Frequency Therapeutics' managers, analysts, and investors.Environmental | Governance | Social |
Frequency Fundamentals
| Return On Equity | -0.75 | ||||
| Return On Asset | -0.35 | ||||
| Current Valuation | 225 M | ||||
| Shares Outstanding | 9.37 M | ||||
| Shares Owned By Insiders | 6.44 % | ||||
| Shares Owned By Institutions | 94.13 % | ||||
| Number Of Shares Shorted | 751.59 K | ||||
| Price To Book | 1.78 X | ||||
| EBITDA | (80.9 M) | ||||
| Net Income | (81.17 M) | ||||
| Total Debt | 33.21 M | ||||
| Book Value Per Share | 19.28 X | ||||
| Cash Flow From Operations | (67.28 M) | ||||
| Short Ratio | 7.19 X | ||||
| Earnings Per Share | (9.42) X | ||||
| Target Price | 139.91 | ||||
| Number Of Employees | 101 | ||||
| Market Capitalization | 320.21 M | ||||
| Total Asset | 221.66 M | ||||
| Retained Earnings | (183 M) | ||||
| Working Capital | 153.25 M | ||||
| Net Asset | 221.66 M |
About Frequency Therapeutics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Frequency Therapeutics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Frequency Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Frequency Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Frequency Therapeutics
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Frequency Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Frequency Therapeutics will appreciate offsetting losses from the drop in the long position's value.Moving together with Frequency Stock
Moving against Frequency Stock
| 0.74 | ALTS | ALT5 Sigma Symbol Change | PairCorr |
| 0.48 | BMY | Bristol Myers Squibb Earnings Call This Week | PairCorr |
| 0.47 | BFRI | Biofrontera | PairCorr |
| 0.43 | EHAB | Enhabit | PairCorr |
The ability to find closely correlated positions to Frequency Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Frequency Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Frequency Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Frequency Therapeutics to buy it.
The correlation of Frequency Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Frequency Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Frequency Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Frequency Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Frequency Therapeutics Piotroski F Score and Frequency Therapeutics Altman Z Score analysis. To learn how to invest in Frequency Stock, please use our How to Invest in Frequency Therapeutics guide.You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Frequency Therapeutics. If investors know Frequency will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Frequency Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Frequency Therapeutics is measured differently than its book value, which is the value of Frequency that is recorded on the company's balance sheet. Investors also form their own opinion of Frequency Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Frequency Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Frequency Therapeutics' market value can be influenced by many factors that don't directly affect Frequency Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Frequency Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Frequency Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Frequency Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.